A detailed history of Hillman Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Hillman Capital Management, Inc. holds 231,150 shares of PFE stock, worth $6.07 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares
231,150
Previous 232,142 0.43%
Holding current value
$6.07 Million
Previous $6.44 Million 0.4%
% of portfolio
2.35%
Previous 2.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $25,057 - $29,363
-992 Reduced 0.43%
231,150 $6.47 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $1.15 Million - $1.32 Million
44,347 Added 23.61%
232,142 $6.44 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $4.91 Million - $6.37 Million
187,795 New
187,795 $5.41 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $7.29 Million - $10.8 Million
-176,532 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $291,509 - $374,469
7,427 Added 4.39%
176,532 $7.59 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $16,159 - $18,306
450 Added 0.27%
169,105 $6.62 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $2.02 Million - $2.27 Million
60,187 Added 55.49%
168,655 $6.11 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $630,307 - $801,489
18,832 Added 21.01%
108,468 $3.99 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $3,492 - $4,097
-110 Reduced 0.12%
89,636 $3.29 Million
Q2 2020

Aug 04, 2020

BUY
$30.12 - $36.54 $210 - $255
7 Added 0.01%
89,746 $2.94 Million
Q1 2020

Apr 29, 2020

BUY
$27.03 - $38.62 $163,044 - $232,955
6,032 Added 7.21%
89,739 $2.93 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $2.76 Million - $3.13 Million
83,707 New
83,707 $3.28 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hillman Capital Management, Inc. Portfolio

Follow Hillman Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillman Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillman Capital Management, Inc. with notifications on news.